Concepedia
Statistics
Publications
3
Citations
120
H-Index
Active since
2003
Affiliations
Heidelberg University(Current)
German Cancer Research Center
University Hospital Heidelberg
Robert Figl is an author at Heidelberg University specializing in tumor microenvironment, pathology, and medicine.
Top concepts
MedicinePathologyTumor MicroenvironmentHealthOncologyImmunologyDermatologySclerodermaPharmacologyCancer Therapy
Publications per year
2003–2007
Randomized phase II study of weekly paclitaxel versus paclitaxel and carboplatin as second-line therapy in disseminated melanoma
C. Zimpfer-Rechner, Udo Hofmann, Robert Figl et al. · Melanoma Research · 2003 · 72 citations
Cancer Management, Pathology, Phase Ii Study +19
Clinical Phase II Study of Pegylated Liposomal Doxorubicin as Second-Line Treatment in Disseminated Melanoma
M. Şahin Uğurel, Dirk Schadendorf, Wolfram Fink et al. · Oncology Research and Treatment · 2004 · 36 citations
Jo-1 positive paraneoplastic systemic sclerosis in a patient with metastatic melanoma.
A. Thoelke, Hans‐Peter Schmid, Robert Figl et al. · PubMed · 2007 · 12 citations
Autoimmune Disease, Systemic Scleroderma, Surgical Pathology +13
1–3 of 3